The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as ...

The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older and those 12 to 64 years old with at least one underlying condition that could put them at ...

Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...

Offit, who sits on the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC), made the comments after criticizing Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.

The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.

It scares me to think of what’s ahead,” said Michael Osterholm, director of the University of Minnesota’s Center for ...

(HealthDay News) — The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

U.S. Health Secretary Robert F. Kennedy Jr. on Wednesday named eight new vaccine policy advisers to replace the panel that he ...

Robert F. Kennedy Jr. purged all previous members of the vaccine panel and said appointing new ones would restore public ...